It was found that MMP-2 is the initiator of BBB derangement following cerebral ischemia, while MMP-9 is the principal contributor to BBB dysregulation in the delayed phase after ischemic stroke (Lakhan et al. 2013). The gene discussed is MMP9; the disease is Cerebral ischemia.